申请人:SmithKline Beecham Corporation
公开号:US20010031877A1
公开(公告)日:2001-10-18
The invention relates to (E)-&agr;-[2-n-butyl-1-[(4-carboxyphenyl)methyl]-1-H-imidazol-5-yl]methylene-2-thiopheneproprionic acid monomethanesulfonate dihydrate, a process for its production, compositions containing the compound and methods of using the compound to block angiotensin II receptors and to treat hypertension, congestive heart failure and renal failure.
该发明涉及(E)-α-[2-正丁基-1-[(4-羧基苯基)甲基]-1H-咪唑-5-基]亚甲基-2-噻吩丙酸甲磺酸单水合物的制备方法,含有该化合物的组合物以及使用该化合物阻断血管紧张素II受体和治疗高血压、充血性心力衰竭和肾衰竭的方法。